Revenue - Additional Information (Details) $ in Thousands	1 Months Ended		3 Months Ended		6 Months Ended
	Oct. 31, 2021 USD ($)	Jul. 31, 2021 USD ($)	Jun. 30, 2022 USD ($)	Jun. 30, 2021 USD ($)	Jun. 30, 2022 USD ($) Segment	Jun. 30, 2021 USD ($)	Apr. 30, 2022 USD ($)	Dec. 31, 2021 USD ($)
Disaggregation Of Revenue [Line Items]
Number of reportable segments | Segment					1
Revenues					$ 0
Net accounts receivable from customers			$ 636		636			$ 183
RADx Initiative
Disaggregation Of Revenue [Line Items]
Revenue received in completion of second stage			0	$ 0	700	$ 7,000
Potential milestone payment	$ 2,000	$ 4,000
Term of contract	Jan. 30, 2022
NIH
Disaggregation Of Revenue [Line Items]
Additional funding available under extension							$ 1,000
Grant revenue recognized			$ 100	$ 100	$ 300	$ 100
Minimum
Disaggregation Of Revenue [Line Items]
Percentage of product revenue					10.00%